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Abstract
The aim of this study was to investigate the nature and severity of the arm complaints among breast cancer patients after axillary
lymph node dissection (ALND) and to study the effects of this treatment-related morbidity on daily life and well-being. 400 women,
who underwent ALND as part of breast cancer surgery, filled out a treatment-specific quality of life questionnaire. The mean time
since ALND was 4.7 years (range 0.3–28 years). More than 20% of patients reported pain, numbness, or loss of strength and 9%
reported severe oedema. None of the complaints appeared to diminish over time. Irradiation of the axilla and supraclavicular
irradiation were associated with a 3.57-fold higher risk of oedema (ods ratio (OR) 3.57; 95% confidence interval (CI) 1.66–7.69)
causing many patients to give up leisure activities or sport. Women who underwent irradiation of the breast or chest wall more
often reported to have a sensitive scar than women who did not receive radiotherapy. Women <45 years of age had an approxi-
mately 6 times higher risk of numbness of the arm (OR 6.49; 95% CI 2.58–16.38) compared with those565 years of age; they also
encountered more problems doing their household chores. The results of the present study support the introduction of less invasive
techniques for the staging of the axilla, sentinel node biopsy being the most promising. # 2001 Elsevier Science Ltd. All rights
reserved.
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1. Introduction
For several decades, axillary lymph node dissection
(ALND) has been standard in the surgical treatment of
patients with invasive breast cancer. The aim originally
was to obtain regional control and it has become a cri-
tical element in adjuvant therapy decision-making.
However, it has become increasingly apparent that
ALND may also cause severe morbidity, such as
oedema, pain, numbness, loss of strength and impaired
range of motion of the involved arm.
Although the physical problems due to ALND are
well documented [1–13], there are only a few studies in
which the psychological morbidity and the effects of
arm complaints on everyday life have been studied [14–
16]. Tobin and colleagues reported that patients with
oedema due to ALND had more psychosocial and
adaptational problems than a comparable group of
patients without oedema [14]. For instance, women with
oedema had less interest in maintaining family relation-
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ships, were less active socially and had fewer goals as far
as work and career are concerned. In addition, they
reported that finding the right clothing to cover the
condition of the arm was often a definite problem. Psy-
chological problems, such as a negative self-esteem and
a negative body-image, were also associated with arm
complaints. Moreover, patients with lymph oedema
reported feeling helpless or losing control. Maunsell and
colleagues found that breast cancer patients with severe
ALND-related arm complaints showed less interest in
their personal appearance and were less active sexually
[15].
The present questionnaire-based study focuses on the
frequency and severity of physical and psychological
complaints and problems in daily life after axillary dis-
section. In addition, we tried to determine which patient
and treatment characteristics were associated with the
various levels of complaints. The results of the present
study are relevant to the discussion on the introduction
of less invasive techniques for staging of the axilla, such
as sentinel node biopsy [17–19].
2. Patients and methods
2.1. Patients
The study was set up and coordinated by the Com-
prehensive Cancer Centre South in Eindhoven and car-
ried out by the Section of Clinical Health Psychology of
Tilburg University. Eight Departments of Surgery, one
Department of Radiotherapy and one Department of
Internal Medicine of eight community hospitals in the
south east of The Netherlands participated in the study.
Approval was obtained from the medical ethical com-
mittees of the hospitals and the Comprehensive Cancer
Centre South.
Between December 1998 and May 1999, specialists
approached all eligible breast cancer patients during
their scheduled follow-up. All patients had undergone
ALND, had finished their treatment at least 3 months
before (including radiation and/or adjuvant chemo-
therapy), and had no clinical signs of locoregional
recurrence or distant metastasis. In order to prevent
selection bias, specialists were requested to approach all
patients consecutively. Informed consent was obtained
and the sequence of ALND and primary and adjuvant
treatment was indicated on a special form. In addition,
swelling of the arm was assessed by measurement of the
circumference of the arm 10 cm above and below the
olecranon process. All clinical information and the
consent form were sent to the Research Department of
the Comprehensive Cancer Centre South, from which
the patients received a questionnaire in a prepaid envel-
ope. In total, 465 questionnaires were sent and 400
(86%) were returned (Table 1).
Table 1
Patient and treatment characteristics
Characteristic n (%)





Time since axillary lymph node









Breast conservation 237 (59)
Primary treatment, radiotherapy
No radiotherapy 112 (28)
Irradiation of breast or chest wall,
without axillary or supraclavicular field
215 (54)


































Secondary or professional 230 (58)
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Data on primary and adjuvant treatment, nodal sta-
tus and field descriptors of radiation were obtained
from the medical records and the database of the Eind-
hoven Cancer Registry. According to regional treatment
guidelines [20], the borders of the ALND consisted of
the latissimus dorsi muscle (dorsal), the thoracic wall
below the major and minor pectoral muscles (ventral),
and the lower border of the axillary vein (cranial).
Aftercare in most hospitals consisted of physical ther-
apy varying from several days to a week, and at dis-
charge patients were instructed by a trained nurse to
resume normal use of the arm and to do exercises. Irra-
diation of the axilla and the supraclavicular region was
recommended for patients with inadequate ALND,
extracapsular extension of tumour growth or nodal
involvement in the apex of the axilla. The radiation dose
and dose specification varied with time. The axillary
field was usually exposed to 52.5 Gy (25 fractions) and
the supraclavicular field to 40 Gy (20 fractions). The
dose specification varied from 30 to 50 mm below the
surface of the skin.
2.2. Questionnaire
To measure the problems of ALND, a treatment-spe-
cific questionnaire was developed. For this purpose, a
literature study was conducted, medical specialists were
interviewed, existing questionnaires were screened and
two focus meetings were held with breast cancer
patients who had undergone axillary lymph node dis-
section at 1 year before. The questionnaire was vali-
dated in a pilot study of 45 patients, 15 of whom were
interviewed afterwards to check on content validity [21].
After validation, 102 items remained in the ques-
tionnaire, covering five domains of quality of life: (1)
physical functioning; (2) psychological functioning; (3)
level of independence; (4) social relationships; and (5)
environment. Response format was a four-point Likert
scale (ranging from ‘not at all’ to ‘very much’, or
from ‘never’ to ‘always’. For this study, 25 items were
selected on the basis of clinical relevance. We ensured
that all domains were covered adequately by the 25
items.
One extra question was added to assess the presence
of comorbidity (e.g. complaints or diseases which were
not located in the arm or shoulder). Comorbidity
was reported by 144 of the 400 patients (36%). This
included: (1) back problems, symptoms of rheumatoid
arthritis, arthrosis, hernia nuclei pulposi (n=83);
(2) gastro-intestinal symptoms (n=7); (3) headaches
or migraine (n=2); (4) myalgic encephalomyopathy
(ME) or encephalomyelitis (n=2); (5) a mixed category,
e.g. multiple sclerosis, cardiovascular disease, hot flu-
shes, toothaches and varicose veins (n=6); and (6)
burning sensation or pain in the treated breast and ribs
(n=44).
2.3. Statistics
A multivariate logistic regression analysis was applied
to assess the association between patient and treatment
characteristics and the risk of complaints. For this pur-
pose, the original four-point Likert-scale responses were
dichotomised. Response categories 2 (i.e. ‘often’ or
‘much’) and 3 (i.e. ‘always’ or ‘very much’) were recoded
into 1, which means that the complaint was present.
Values 0 (i.e. ‘never’ or ‘not at all’) and 1 (i.e. ‘some-
times’ or ‘a little’) were reclassified into 0, meaning that
the complaint was absent. We calculated odds ratios
(ORs) and 95% confidence intervals (95% CIs) for the
risk of complaints. The following covariates were inclu-
ded in the regression analysis:
. age: younger than 45, or 45–54, or 55–64 years of
age versus 65 years or older;
. time since diagnosis: 1.1–1.3, or 3.1–5.0 or >5
years ago versus 41.0 year ago;
. type of surgical treatment: breast-conserving
treatment versus mastectomy;
. radiation therapy: axillary or supraclavicular irra-
diation versus no axillary irradiation and breast or
chest wall irradiation versus no irradiation;
. adjuvant chemotherapy: yes versus no;
. adjuvant hormonal therapy: yes versus no;
. ALND ipsilateral to handedness: axillary dissec-
tion on the side of hand preference versus axillary
dissection not on the side of hand preference (i.e.
contralateral);
. civil status: living with a partner (i.e. either mar-
ried or unmarried) versus living without a partner
(i.e. single, widowed or divorced);
. children: having children versus having no children;
. educational level: secondary or higher education
versus primary education;
. occupation: being employed (i.e. paid work) versus
non-paid work or housewives;
. health care insurance: private versus public health
care insurance;
. co-morbidity: present versus absent.
All P values were two-sided and only variables with a
value <0.05 were considered to be statistically sig-
nificant and were kept in the model after a stepwise
backward selection procedure.
3. Results
3.1. Frequency and severity of arm problems and arm-
related complaints
The frequency and severity of arm complaints and
arm-related complaints are presented in Table 2. Fre-
quently reported (i.e. 520%) physical complaints were:
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pain (21%), numbness (22%), loss of strength (28%),
sensitive scar (35%) and shoulder, neck or back com-
plaints (20%). Severe oedema was reported by approxi-
mately 9% of respondents. Measurement of forearm
and upper arm girth showed a difference of 2 cm or
more between the right and the left arm in 25 of the 35
patients (71%) reporting much or very much oedema,
whereas of the 365 patients reporting no or only a little
lymph oedema, a difference of 2 cm or more between the
forearms or upper arms was measured in only 63 (17%).
Of all 400 patients, 63% had at least one physical
complaint and 37% were free of complaints. 51% of the
patients indicated that there had been very little
improvement in their complaints over the course of time.
25–35% of the patients reported that they also had
problems performing daily activities, such as household
chores or lifting heavy objects. 21% said that they fre-
quently needed to rest the arm, 24% exercised the
affected arm and 22% had learned to do things with the
other arm.
As far as mental functioning was concerned, 18% of
patients feared the development of oedema and 21%
found it a nuisance to be careful of your arm. 27% of
the women avoided wearing revealing clothing.
30% of respondents felt that they had received little
sympathy from others for their complaints and 7% said
that they could not discuss their problems at home. 15–
19% of patients of this study reported that they were
somewhat dissatisfied with the attention they received
from their physician and 14% of respondents had pro-
blems with transportation. 37% of the women reported
that they had to give up a hobby or sport due to
ALND-related morbidity.
3.2. Risk factors
In Tables 3 to 7, ORs which resulted from the multi-
variable logistic regression analysis are presented for the
domain-specific ALND-related complaints.
After adjustment for confounders, the patients with
axillary or supraclavicular irradiation were found to
have a 3.57-fold higher risk to develop lymph oedema
compared with those who had not been irradiated (95%
CI 1.66–7.69) (Table 3). The presence of comorbidity
significantly increased the risk of pain, oedema, numb-
ness, loss of strength in the arm or shoulder, shoulder,
back or neck complaints (Table 3). None of the physical
complaints seemed to diminish over time (Table 3). The
Table 2
Frequency and severity of complaints after axillary lymph node dissection according to the self-rating questionnaire (n=400)
Domain Never/










Do you have pain in your arm or shoulder? 36 43 17 4 1
Do you have swelling or oedema? 58 32 6 3 1
Do you have a numb feeling in your arm or shoulder? 34 44 16 6 1
Do you have a sensitive scar? 26 47 31 4 2
Do you have less strength in arm or shoulder? 21 41 23 5 1
Do you have shoulder, neck or back complaints? 52 26 16 4 3
Did your complaints diminish after some time? 28 23 19 15 17
Level of independence
Do you take moments of rest to relieve your complaints? 33 45 18 3 2
Do you use a pillow for arm support when resting? 69 17 10 3 1
Do you do things with the other hand? 43 30 17 5 5
Do you have problems lifting heavy things? 22 41 24 11 3
Are you still able to do household chores as before? 7 18 33 40 2
Do you exercise your arm? 40 33 16 8 4
Mental functioning
Are you afraid of oedema? 40 40 9 9 3
Are you bothered that others have to do your chores? 39 23 16 11 12
Do you avoid wearing clothing which might reveal scars? 46 22 12 15 5
Is it a nuisance to have to be careful of your arm? 31 40 13 8 9
Do you think that you should not use your arm too much? 35 41 17 6 2
Social Support
Do you get sympathy from others for your arm complaints? 11 19 27 15 29
Are you able to talk about your arm complaints at home? 7 15 25 24 30
Is your partner supportive? 3 5 14 39 40
Environment
Are your complaints taken seriously by your physician? 3 12 22 36 28
Is your physician willing to discuss your complaints with you? 2 17 26 30 25
Does your arm cause problems when you ride a bike? 47 26 11 3 14
Have you given up hobbies or sport? No: 58 Yes: 37 5
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Table 3
Odds ratios for complaints in the physical functioning domaina
Complaint Odds ratio (95% CI)
Having pain in arm or shoulder
Comorbidity versus no comorbidity 3.38 (2.03–5.64)
Having swelling or oedema
Axillary or supraclavicular irradiation versus no irradiation 3.57 (1.66–7.69)
Co-morbidity versus no comorbidity 3.08 (1.49–6.38)
Having a numb feeling in the arm or shoulder.
Age <45 years versus 65+ years 6.49 (2.58–16.34)
Age 45–54 years versus 65+ years 2.83 (1.26–6.35)
Age 55–64 years versus 65+ years 2.67 (1.22–5.83)
Having children versus having no children 0.45 (0.21–0.94)
Private versus public health care insurance 0.38 (0.21–0.70)
Comorbidity versus no comorbidity 2.33 (1.36–3.97)
Having a sensitive scar
Irradiation of breast or chest wall versus no irradiation 1.79 (1.10–2.91)
Having less strength in arm or shoulder
ALNDb 3.1–5.0 years ago versus41.0 year ago 1.91 (1.11–3.30)
Comorbidity versus no comorbidity 1.80 (1.12–2.85)
Having shoulder, neck or back complaints
Co-morbidity versus no comorbidity 2.72 (1.62–4.59)
95% CI, 95% confidence interval.
a Results should be interpreted as follows: e.g. patients with axillary or supraclavicular irradiation showed a 3.57 times higher risk of having
swelling or oedema.
b ALND, axillary lymph node dissection.
Table 4
Odds ratios for complaints in the level of independence domain
Complaint Odds ratio (95% CI)
Taking moments of rest to relieve complaints
Comorbidity versus no comorbidity 1.94 (1.17–3.21)
Using a pillow for arm support when resting
Age 55–64 years versus 65+ years 2.09 (1.15–3.81)
Doing things with the other hand
Age 45–54 years versus 65+ years 2.10 (1.04–4.24)
Age 55–64 years versus 65+ years 2.33 (1.21–4.49)
Secondary education versus primary education 0.56 (0.33–0.96)
Axillary or supraclavicular irradiation versus no irradiation 3.67 (1.94–6.93)
ALND on the side of hand preference versus contralateral 0.58 (0.34–0.98)
Comorbidity versus no comorbidity 2.54 (1.49–4.34)
Having problems lifting heavy things
Comorbidity versus no comorbidity 1.88 (1.21–2.93)
Still being able to do household chores as before
Age <45 years versus 65+ years 0.44 (0.21–0.91)
Private versus public health care insurance 1.91 (1.10–3.32)
Breast conservation versus mastectomy 0.57 (0.34–0.97)
Comorbidity versus no comorbidity 0.35 (0.21–0.59)
Doing arm exercises
Age 55–64 versus 65+ years 2.50 (1.47–4.25)
ALND 1.0–3.0 years ago versus41.0 year ago 0.50 (0.27–0.93)
ALND 3.0–5.0 years ago versus41.0 year ago 0.30 (0.14–0.65)
ALND >5.0 years ago versus41.0 year ago 0.17 (0.07–0.37)
Higher education versus primary education 2.06 (1.04–4.07)
95% CI, 95% confidence interval; ALND, axillary lymph node dissection.
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risk of numbness in the arm appeared to be 6.49 times
higher for women <45 years than for women of 65
years or older (95% CI 2.58–16.34) (Table 3).
Patients who received axillary or supraclavicular irra-
diation were 3.67 times more likely to relieve the affec-
ted arm by doing things with the other arm (95% CI
1.94–6.93) (Table 4). Younger patients, patients who
underwent breast conservation and those with public
healthcare insurance experienced more problems doing
household chores after ALND (Table 4). Patients with a
higher education were more likely to do arm exercises.
The presence of comorbidity significantly diminished
the level of independence (Table 4). Mental functioning
appeared to be worse among patients with comorbidity
(Table 5).
Higher educational level and private healthcare
insurance were associated with the social support
domain and the environment domain (Tables 6 and 7).
Patients with a higher or secondary educational level
appeared to receive more support and sympathy from
others than patients who had only a primary education
(Table 6), and they also appeared to be more mobile
(Table 7). The risk of having to give up hobbies or
sports was 1.89 times higher for patients with axillary or
supraclavicular irradiation (95% CI 1.05–3.40)
(Table 7). Women with private healthcare insurance,
however, experienced fewer problems continuing leisure
activities (Table 7). Patients with comorbidity had more
problems with social support, continuing leisure activ-
ities and transportation. They also appeared to be less
Table 5
Odds ratios for complaints in the mental functioning domain
Complaint Odds ratio (95% CI)
Being afraid of oedema
Comorbidity versus no comorbidity 1.92 (1.13–3.27)
Being bothered that others have to take over chores
Working professionally versus housewife 0.46 (0.25–0.84)
ALND 1.0–3.0 years ago versus41.0 year ago 0.56 (0.33–0.94)
Comorbidity versus no comorbidity 2.01 (1.24–3.27)
Avoiding clothing which might reveal scars
Age 55–64 years versus 65+ years 1.70 (1.01–2.84)
ALND >5.0 years ago versus41.0 year ago 2.19 (1.27–3.77)
Private versus public healthcare insurance 1.79 (1.08–2.97)
Breast conservation versus mastectomy 0.39 (0.24–0.64)
Hormonal therapy versus none 2.17 (1.24–3.60)
Finding it a nuisance to be careful with the arm
Chemotherapy versus none 2.23 (1.20–4.13)
Comorbidity versus none 1.97 (1.17–3.31)
Thinking that the arm should not be used too much
Secondary education versus primary 0.51 (0.31–0.83)
Chemotherapy versus none 2.13 (1.14–4.00)
Without partner versus with partner 1.73 (1.02–2.95)
Comorbidity versus no comorbidity 1.93 (1.16–3.19)
95% CI, 95% confidence interval; ALND, axillary lymph node dissection.
Table 6
Odds ratios for complaints in the social support domain
Complaint Odds ratio (95% CI)
Getting sympathy from others for the arm complaints
Secondary education versus primary education 2.25 (1.30–3.91)
Higher education versus primary education 3.72 (1.56–8.85)
Comorbidity versus no comorbidity 0.59 (0.36–0.98)
Being able to talk about the arm complaints at home
Chemotherapy versus no chemotherapy 3.73 (1.49–9.37)
Without partner versus with partner 0.26 (0.14–0.46)
Having a partner who is supportivea
Comorbidity versus no comorbidity 0.21 (0.08–0.58)
95% CI, 95% confidence interval.
996 J.M.M.A. Ververs et al. / European Journal of Cancer 37 (2001) 991–999
satisfied with the attention that was paid to their pro-
blems by their treating physician (Table 7).
4. Discussion
The purpose of this study was not only to assess the
nature and severity of the morbidity after ALND, but
also to determine whether complaints interfere with
daily life and psychosocial functioning of the patient.
To gain insight into the nature and severity of the
complaints related to ALND, a newly designed treat-
ment-specific questionnaire was used since existing
questionnaires failed to cover the full range of the pro-
blems which confront patients after ALND. Our study
demonstrated that almost two-thirds of the patients
experienced at least one of the following physical pro-
blems: pain, numbness, a sensitive scar, loss of strength,
swelling or oedema, and shoulder, neck or back com-
plaints. More limited approaches to the axilla, like axil-
lary node sampling or sentinel node biopsy, appear to
cause less physical complaints [22,23]. We are aware
that our questionnaire-based study is not suited for
investigating the hypothesis whether these procedures
will also lead to improved psychological well-being and
that only a randomised trial can give a valid answer to
this question. Less invasive procedures, however, will
enable earlier discharge, which in itself has been shown
to have positive psychosocial effects [24].
9% of the women in this study reported to have much
or very much lymph oedema. In other studies, the inci-
dence of oedema varied between 5 and 30%, depending
on the definition that was used. In most cases, oedema
has been defined as the absolute difference in arm cir-
cumference between the treated and untreated sides and
was not based on a patient’s self-report. One study, in
which self-rating and objective measurement of oedema
were compared, showed that self-rating resulted in a
lower incidence of oedema than objective measurement
[16]. In most studies, severe disabling swelling or
oedema was diagnosed in less than 10% of the patient
population [6,7].
The highly elevated risk of severe arm oedema for
patients who underwent axillary or supraclavicular
irradiation in addition to dissection, which has been
reported previously [1–3,8,12,13], is probably associated
with disturbances in arterial and venous lymph flow.
The risk and severity of oedema were also suggested to
be associated with the extent of the dissection [1], obe-
sity [4,10] and hypertension [5]. However, we did not
include these variables in the present study. The dis-
abling effect of lymph oedema is reflected by the fact
that when the treated axilla had been irradiated, the
women were more inclined to do things with their other
hand and more often had to give up hobbies or sports.
Approximately 20% of the women suffered pain or a
great deal of pain in the operated arm or shoulder,
which is comparable to other studies. For instance, Van
Dam and colleagues diagnosed pain in 23 of 71 (32%)
of examined and interviewed patients and pain was
moderate to severe in 12% of all cases [7]. In a study by
Ivens and coworkers, 33% of the sample suffered pain
[6]. In a recent study by Hack and colleagues, of 222
breast cancer patients who had undergone ALND, pain,
numbness or weakness of arm and shoulder was listed
by 72% of all women; 73% had a limited range of
motion [9]. They reported that pain was mild to mod-
erate in most cases, was experienced more frequently by
younger women and also appeared to be associated with
chemotherapy and the number of lymph nodes
removed. Tasmuth and colleagues also found that most
complaints of pain were mentioned by younger women
and the group of patients that had received chemo-
therapy in addition to irradiation [11]. However, the
results of these studies are difficult to compare with ours
as we did not use a standardised pain score. Pain in the
arm or shoulder after axillary dissection is likely to be
due to transection of one or more of the branches of the
Table 7
Odds ratios for complaints in the environment domain
Complaint Odds ratio (95% CI)
Complaints are taken seriously by the physician
Co-morbidity versus no co-morbidity 0.35 (0.19–0.64)
Being given enough time to discuss problems with the physician
Co-morbidity versus no co-morbidity 0.56 (0.33–0.97)
Having to give up hobbies or sports
Private versus public health care insurance 0.56 (0.34–0.90)
Axillary or supraclavicular irradiation versus no irradiation 1.89 (1.05–3.40)
Comorbidity versus no comorbidity 3.01 (1.90–4.76)
Arm complaints causing problems when riding a bike
Higher education versus primary education 0.18 (0.04–0.78)
Comorbidity versus no comorbidity 2.74 (1.49–5.05)
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intercostobrachial nerve by the surgeon. Sensoric inner-
vation of quite a large part of the arm and axillary
region can be disturbed afterwards [25,26]. In the pre-
sent study, none of the treatment variables was asso-
ciated with pain in the arm or shoulder.
In addition to pain in the arm or shoulder, a sub-
stantial number of patients (11%) mentioned that they
felt a burning pain in the breast or ribs that was more
bothersome than the side-effects of ALND. This com-
plaint was reported more often after breast conservation
and has also been reported in other studies [11,27].
Adjuvant irradiation of the breast seems to play an
important role in the development of these complaints.
In a study by Carpenter, almost one-third of the patients
had severe postoperative pain in the treated breast [27].
The present study revealed an association between the
risk of developing a sensitive scar and radiation.
The results of the current study further suggested that
none of the complaints diminished over time. On the
contrary, the risk of loss of strength was even higher for
the group that had been treated more than 3 years ago
than for the more recently treated groups. Hack and
coworkers also found that the pain was fairly perma-
nent since it was not inversely related to the number of
years that had passed since initial diagnosis [19]. Only a
few patients practised and exercised the arms regularly
more than 5 years after treatment. Little is known,
however, about the effectiveness of these exercises.
A number of problems were clearly associated with
age. The much higher risk of numbness for younger
women can perhaps be explained by the fact that some
older patients underwent less extensive dissection on
account of their poor physical health. A more aggressive
approach to the axilla might have been chosen for
younger patients to optimise their chances of cure,
probably resulting in a higher risk of tissue damage.
This hypothesis is supported by the results of another
study in the south east of The Netherlands among 6663
breast cancer patients, in which the mean number of
nodes examined appeared to decrease with age from
11.1 for patients <40 years of age to 9.3 for those of 80
years or older [28]. Younger women also encountered
more problems doing their household chores, which
may be explained by the fact that younger women often
combine a job, taking care of children and running the
household; as a result they may be under greater physi-
cal strain so that the problems with the arm or shoulder
are intensified.
Higher educational level predicted fewer problems in
the social support and environment domain. This may
imply that women with a higher education are more
likely to ask for support, can cope with problems in these
domains more easily or have more resources to do so.
Many ALND-related problems in our study were
associated with comorbidity or pain in the breast or
ribs. The explanation for this finding could be that the
questionnaire might have given the opportunity for at
least some of these patients to express (health) problems
which are not related to ALND. Comorbidity also
affected satisfaction with healthcare providers. Nearly
half of this patient group were not satisfied with the
time available to discuss their problems during follow-
up visits or felt that their complaints were not taken
seriously by their treating physician.
Our questionnaire survey among breast cancer survi-
vors demonstrates that ALND is associated with a wide
range of problems. These problems pertain not only to
physical or mental health but also social support, daily
activities such as household chores, transportation,
recreation and sports. Our findings support the further
technical development and implementation of less inva-
sive techniques for staging of the axilla, sentinel node
biopsy being the most promising. It should be realised,
however, that those patients with a positive sentinel
node will still need to undergo treatment of the axilla
either by ALND with or without radiotherapy or by
radiotherapy alone and will thus remain at risk for the
physical and psycho-social side-effects.
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